News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Join FDA Oncology‘s Conversations On Cancer event
Jan 6, 2025, 19:13

Join FDA Oncology‘s Conversations On Cancer event

FDA Oncology shared a post on X:

“Join us for a Conversations On Cancer event on Jan 14, 2025.

Time: 10:00-11:00 AM ET/16:00-17:00 CET.

Topic: Cervical Cancer Treatment Innovation: A Collaborative Discussion.

Register now.”

cancer cervical cancer cervical cancer treatment FDA Oncology OncoDaily Oncology
Special Coverage
Oncolibrary
Jun 1, 2025, 18:59
SERENA-6 Trial at ASCO 2025: Camizestrant Plus CDK4/6i Improves Outcomes in HR+/HER2– Advanced Breast Cancer with ctDNA-Detected ESR1 Mutations
Blog
Jun 1, 2025, 18:25
Project Cure CRC has awarded 4 new grants - Colorectal Cancer Alliance
Blog
Jun 1, 2025, 18:09
Michael Jefford: Grateful for ASCO25’s Valuable Survivorship Session
Stories
Jun 1, 2025, 17:19
Shrenik Shah’s Story from Cancer Survivor to Global Advocate: From Silence to Stages
Insight
Jun 1, 2025, 17:02
Paolo Tarantino: The practice-changing results from ASCENT-04 presented by Sara Tolaney
Blog
Jun 1, 2025, 16:55
Oriol Mirallas: Early Data on SYNC-T Therapy for mCRPC Presented at ASCO 2025
Blog
Jun 1, 2025, 16:52
Armando Orlandi: Racial Disparities in HER2+ Breast Cancer Outcomes at ASCO 2025
Insight
Jun 1, 2025, 16:46
Shanda Blackmon: First trial of CAR-T cell cancer treatment for solid tumor response
Oncolibrary
Jun 1, 2025, 16:39
MATTERHORN Trial at ASCO 2025: Durvalumab plus FLOT Shows Significant Improvement of EFS in Resectable Gastric and GEJ Cancer Treatment
Opinion
Jun 1, 2025, 16:37
Massimo Di Maio: Overall Survival Analysis Should NOT be Adjusted for Subsequent Treatments
Blog
Jun 1, 2025, 16:37
Paolo Tarantino Shares DB06 Biomarker Analysis Insights from ASCO 2025
Insight
Jun 1, 2025, 16:36
Rebecca Shatsky: It’s high time for an oral taxane in breast cancer